Skip to main content

Table 1 Epidemiological and clinical parameters of 61 patients with MMHN diagnosed in Slovenia, 1985–2013

From: Mucosal melanoma of the head and neck: a population-based study from Slovenia, 1985-2013

Characteristic

All cases

Sinonasal tract

Oral cavity & oropharynx

p-value 

N = 61 (%)

N = 44 (%)

N = 16 (%)

Age at diagnosis (years)

 Median

75.5

77.0

68.2

0.059

 Range

25.9–91.8

40.0–91.8

25.9–87.3

 

Sex

 Male

32 (53)

20 (46)

11 (69)

0.110

 Female

29 (48)

24 (55)

5 (31)

 

PS WHO

 Grade 0

29 (48)

18 (41)

10 (63)

0.276

 Grade 1

23 (38)

18 (41)

5 (31)

 

 Grade >1

9 (15)

8 (18)

1 (6.3)

 

Duration of symptoms (months)

 Median

2.0

2.0

1.0

0.554

 Range

0.0–12.0

0.0–12.0

0.0–12.0

 

Tumor pigmentation

 Yes

36 (59)

23 (52)

13 (81)

0.165

 No

13 (21)

11 (25)

2 (13)

 

 Unknown

12 (20)

10 (237)

1 (6.3)

 

Overall stage

 1

48 (79)

38 (86)

9 (56)

0.029

 2

10 (16)

4 (9.1)

6 (38)

 

 3

3 (4.9)

2 (4.5)

1 (6.3)

 

TNM stage

 III

21 (34)

16 (36)

4 (25)

0.203

 IVA

30 (49)

19 (43)

11 (69)

 

 IVB

7 (12)

7 (16)

0 (0.0)

 

 IVC

3 (4.9)

2 (4.5)

1 (6.3)

 

Treatment intent

 Curative

48 (79)

33 (75)

14 (88)

0.299

 Palliative

13 (21)

11 (25)

2 (13)

 

Surgery

 No

22 (36)

20 (46)

2 (13)

0.019

 Yes

39 (64)

24 (55)

14 (88)

 

  Open surgery

24 (62)

10 (42)

13 (93)

0.002

  Endoscopic surgery

15 (39)

14 (58)

1 (7.1)

 

Radiotherapy

 No

28 (46)

21 (48)

7 (44)

0.785

 Yes

33 (54)

23 (52)

9 (56)

 

  Definitive

11 (33)

9 (39)

2 (22)

0.066

  Postoperative

16 (49)

8 (35)

7 (78)

 

  Palliative

6 (18)

6 (26)

0 (0.0)

 

Systemic therapy

 Yes

13 (21)

10 (23)

3 (19)

0.741

 No

48 (79)

34 (77)

13 (81)

 

2-year overall survivala

43 (30–55)

40 (26–55)

54 (29–79)

0.548

5-year overall survivala

18 (7.8–29)

20 (7.4–32)

15 (0.0–35)

0.548

  1. a% (95 % confidence interval). N Number of patients